| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on April 3, 2003
Accepted on July 7, 2003
1 First Department of Internal Medicine and Department of Laboratory Medicine, Gunma University School of Medicine, Maebashi 371, Japan
* To whom correspondence should be addressed. E-mail: mmurakam{at}showa.gunma-u.ac.jp.
We identified the presence of iodothyronine deiodinase in AtT-20 mouse pituitary tumor cells which secrete corticotropin. Iodothyronine deiodinating activity in AtT-20 cells fulfills all the characteristics of type 2 iodothyronine deiodinase (D2), including the inhibition by thyroid hormones, the insensitivity to inhibition by 6-propyl-2-thiouracil, and the low Km value for T4. Northern analysis using mouse D2 cRNA probe demonstrated the hybridization signal with approximately 7.0 kb in size in AtT-20 cells. D2 activity and D2 mRNA were stimulated by glucocorticoid in a dose dependent manner, but were not stimulated by testosterone or
-estradiol. D2 expression was stimulated by (Bu)2cAMP, and CRH in a dose dependent manner in the presence of dexamethasone. These results suggest the previously unrecognized role of local thyroid hormone activation by D2 in the regulation of pituitary corticotrophs.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |